Cambridge, Massachusetts-based Biogen Inc. ( BIIB) discovers, develops, manufactures, and delivers therapies for treating ...

Highlights:,Biogen Inc. (BIIB) has underperformed the broader market and key healthcare ETFs in recent years.,The company’s ...

CVS Caremark has removed several therapies to treat patients with diabetes in favor of newer products and generics, and is ...

Biogen (NASDAQ:BIIB – Free Report) had its price objective decreased by Mizuho from $251.00 to $207.00 in a research note published on Thursday,Benzinga reports. Mizuho currently has an outperform ...

We’ve debated immigration since Native Americans encountered a group of migrants from England who decided to settle in ...

Sage Therapeutics discontinued development of its lead candidate dalzanemdor after a third clinical failure, leading analysts ...

(Reuters) -Biohaven said on Monday its experimental treatment for a rare neuromuscular disorder failed to show statistically significant difference in improving motor function in a late-stage trial, ...

Global Hemophilia B Treatment Market Expected to Taste Huge Growth with Emerging Innovations into the New Treatment RegimentRockville, MD, Nov. 25, 2024 (GLOBE NEWSWIRE) -- According to Fact.MR, a ...

During an address to the Bihari diaspora in the US, political strategist Prashant Kishor characterized Bihar as a "failed state," drawing parallels to Sudan and emphasizing the state's dire need ...

A man walks past a corporate office of Adani Group in Gurugram, India, November 22, 2024. REUTERS/Priyanshu Singh/File Photo Adani dollar bond prices fell to almost one-year lows on Monday as ...